4‐Methylumbelliferone Restores Age‐Related Changes in Perineuronal Nets, Memory, and Neuroinflammation
Glia · 2026
DOI: 10.1002/glia.70233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2026. Verfasst von Anda Cimpean und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroregeneration, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic. Hauptthemen laut MEDLINE: Perineuronal Nets, Hymecromone, Aging, Neuroinflammatory Diseases. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Science Foundation, EXREGMED, Grantová Agentura České Republiky.
Abstract (Originalsprache)
Aging‐associated cognitive decline is closely linked to dysregulated glial activity and chronic neuroinflammation, which together constrain neuronal plasticity. Astrocytes and microglia are key regulators of the brain extracellular matrix (ECM), including perineuronal nets (PNNs), whose accumulation during aging contributes to reduced synaptic flexibility. Targeting ECM–glia interactions therefore represents a promising strategy to modulate neuroinflammatory and plasticity‐related processes. Here, we investigated the effects of long‐term oral administration of 4‐methylumbelliferone (4‐MU), an inhibitor of hyaluronan and chondroitin sulfate synthesis, on glial reactivity, ECM remodeling, and cognitive function in aged mice (20–22 months). Aging was associated with PNN remodeling alongside pronounced astrocytic and microglial activation and infiltration of peripheral immune cells. Chronic 4‐MU treatment reduced PNN accumulation to levels observed in younger (10‐month‐old) mice, indicating effective ECM remodeling. Notably, this was accompanied by a marked attenuation of astrocyte and microglial activation and a reduction in immune cell infiltration, suggesting a broad normalization of the neuroinflammatory milieu. Functionally, these glia‐associated changes were paralleled by improved recognition memory, with treated aged mice performing at or above the level of younger controls. Long‐term 4‐MU administration was well tolerated, with no evident adverse effects. Together, our findings identify ECM modulation as a mechanism to regulate glial reactivity and neuroimmune interactions in the aging brain. By targeting hyaluronan‐dependent pathways, 4‐MU links ECM remodeling to suppression of neuroinflammation and restoration of cognitive function, highlighting its therapeutic potential in age‐related neurodegenerative processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroregeneration, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic.
- Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.
- Faculty of Biological Sciences, University of Leeds, Leeds, UK.
ORCID-Profile: Anda Cimpean, Jana Mizerakova, Noelia Martinez-Varea, Lucia Machova Urdzikova, James W Fawcett, Pavla Jendelova, Jessica C F Kwok
Förderung
- Czech Science Foundation
- EXREGMED
- Grantová Agentura České Republiky
Zitieren
APA
Cimpean, A., Mizerakova, J., Martinez-Varea, N., Marekova, D., Machova Urdzikova, L., Fawcett, J. W., Jendelova, P., & Kwok, J. C. F. (2026). 4‐Methylumbelliferone Restores Age‐Related Changes in Perineuronal Nets, Memory, and Neuroinflammation. Glia. https://doi.org/10.1002/glia.70233
Vancouver
Cimpean A, Mizerakova J, Martinez-Varea N, Marekova D, Machova Urdzikova L, Fawcett JW, et al. 4‐Methylumbelliferone Restores Age‐Related Changes in Perineuronal Nets, Memory, and Neuroinflammation. Glia. 2026. doi:10.1002/glia.70233
BibTeX
@article{Cimpean2026,
author = {Cimpean, Anda and Mizerakova, Jana and Martinez-Varea, Noelia and Marekova, Dana and Machova Urdzikova, Lucia and Fawcett, James W and Jendelova, Pavla and Kwok, Jessica C F},
title = {4‐Methylumbelliferone Restores Age‐Related Changes in Perineuronal Nets, Memory, and Neuroinflammation},
journal = {Glia},
year = {2026},
doi = {10.1002/glia.70233}
}
EUVIMED